Occurrence of Total and Proteinase K-Resistant Alpha-Synuclein in Glioblastoma Cells Depends on mTOR Activity.
autophagy vacuoles
cell-clearing systems
glioblastoma multiforme
mechanistic target of rapamycin
qRT-PCR
siRNA
synucleins
transmission electron microscopy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
08 Mar 2022
08 Mar 2022
Historique:
received:
11
01
2022
revised:
01
03
2022
accepted:
07
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Alpha-synuclein (α-syn) is a protein considered to be detrimental in a number of degenerative disorders (synucleinopathies) of which α-syn aggregates are considered a pathological hallmark. The clearance of α-syn strongly depends on autophagy, which can be stimulated by inhibiting the mechanistic target of rapamycin (mTOR). Thus, the overexpression of mTOR and severe autophagy suppression may produce α-syn accumulation, including the proteinase K-resistant protein isoform. Glioblastoma multiforme (GBM) is a lethal brain tumor that features mTOR overexpression and severe autophagy inhibition. Cell pathology in GBM is reminiscent of a fast, progressive degenerative disorder. Therefore, the present work questions whether, as is analogous to neurons during degenerative disorders, an overexpression of α-syn occurs within GBM cells. A high amount of α-syn was documented in GBM cells via real-time PCR (RT-PCR), Western blotting, immunohistochemistry, immuno-fluorescence, and ultrastructural stoichiometry, compared with the amount of β- and γ-synucleins and compared with the amount of α-syn counted within astrocytes. The present study indicates that (i) α-syn is overexpressed in GBM cells, (ii) α-syn expression includes a proteinase-K resistant isoform, (iii) α-syn is dispersed from autophagy-like vacuoles to the cytosol, (iv) α-syn overexpression and cytosol dispersion are mitigated by rapamycin, and (v) the α-syn-related GBM-like phenotype is mitigated by silencing the SNCA gene.
Identifiants
pubmed: 35326535
pii: cancers14061382
doi: 10.3390/cancers14061382
pmc: PMC8946689
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministero della Salute
ID : Ricerca Corrente 2021
Références
Acta Neuropathol. 2000 Feb;99(2):154-60
pubmed: 10672322
Int J Biochem Cell Biol. 2015 Jul;64:25-33
pubmed: 25813876
Oncol Rep. 2010 Feb;23(2):429-36
pubmed: 20043104
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
Oncotarget. 2015 Jun 30;6(18):15882-90
pubmed: 26021816
J Histochem Cytochem. 2001 Dec;49(12):1519-24
pubmed: 11724899
Int J Mol Sci. 2020 Jun 27;21(13):
pubmed: 32604996
Neuro Oncol. 2010 Dec;12(12):1205-19
pubmed: 20861085
Neuron. 2013 Sep 18;79(6):1044-66
pubmed: 24050397
Acta Neuropathol Commun. 2020 Jun 19;8(1):86
pubmed: 32560668
Oncotarget. 2017 May 2;8(18):29574-29599
pubmed: 28418837
Acta Neuropathol. 1994;87(1):86-90
pubmed: 7908155
Neuropharmacology. 2014 Jul;82:132-42
pubmed: 23973294
Int J Mol Sci. 2016 Feb 02;17(2):
pubmed: 26848654
Sci Rep. 2019 Jul 29;9(1):10919
pubmed: 31358782
Science. 2003 Oct 31;302(5646):841
pubmed: 14593171
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):
pubmed: 28108534
Brain Res Mol Brain Res. 1991 Oct;11(3-4):335-43
pubmed: 1661825
PLoS One. 2011;6(5):e19622
pubmed: 21611169
J Microsc. 2000 Jul;199(Pt 1):1-36
pubmed: 10886526
Sci Rep. 2021 Mar 4;11(1):5267
pubmed: 33664298
Dis Model Mech. 2022 Mar 1;15(3):
pubmed: 35023548
Curr Protein Pept Sci. 2018;19(6):598-611
pubmed: 29150919
J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1554-63
pubmed: 24780412
Arch Ital Biol. 2012 Jun-Sep;150(2-3):194-217
pubmed: 23165879
Adv Biol Regul. 2013 May;53(2):202-10
pubmed: 23231881
Mov Disord. 2003 Sep;18 Suppl 6:S21-7
pubmed: 14502652
J Cell Sci. 2013 Jan 15;126(Pt 2):696-704
pubmed: 23203798
Brain Res. 2002 Jun 21;941(1-2):118-26
pubmed: 12031554
Front Neuroanat. 2016 Jul 21;10:78
pubmed: 27493626
JAMA Neurol. 2013 May;70(5):571-9
pubmed: 23459986
Geroscience. 2021 Oct;43(5):2413-2425
pubmed: 34482522
Biochem J. 2017 Jun 6;474(12):2039-2049
pubmed: 28495859
Brain Res. 2010 Feb 8;1313:250-8
pubmed: 20004652
Methods Enzymol. 2009;453:273-86
pubmed: 19216911
Brain Res. 2013 Feb 7;1495:37-51
pubmed: 23261661
J Cereb Blood Flow Metab. 2011 Mar;31(3):913-23
pubmed: 20877387
J Histochem Cytochem. 1999 Nov;47(11):1465-70
pubmed: 10544219
Biochem Biophys Res Commun. 2020 Feb 12;522(3):655-661
pubmed: 31785806
Neuroscience. 2021 Aug 1;468:186-198
pubmed: 34082066
Science. 2001 Feb 16;291(5507):1363-5
pubmed: 11233453
J Neurosci. 2016 Jun 29;36(26):7055-65
pubmed: 27358461
Chemistry. 2018 Oct 17;24(58):15685-15690
pubmed: 30102440
Lancet Neurol. 2011 Nov;10(11):1015-25
pubmed: 22014436
Ann Neurol. 2000 Feb;47(2):201-10
pubmed: 10665491
Int J Mol Sci. 2021 May 20;22(10):
pubmed: 34065350
PLoS One. 2010 May 05;5(5):e10481
pubmed: 20463956
Brain Res. 2019 Sep 15;1719:157-175
pubmed: 31150652
Mov Disord Clin Pract. 2017 Jun 01;4(5):724-732
pubmed: 30363411
Acta Neuropathol. 2003 Aug;106(2):167-75
pubmed: 12783249
Hum Mol Genet. 2011 Sep 1;20(17):3401-14
pubmed: 21642386
Int J Cancer. 2011 Dec 1;129(11):2720-31
pubmed: 21384342
Nature. 2013 Jun 13;498(7453):E4-6; discussion E6-7
pubmed: 23765500
Toxicol Lett. 2021 Nov 1;352:34-45
pubmed: 34562559
J Neural Transm Suppl. 2000;(58):53-63
pubmed: 11128613
Neuropathol Appl Neurobiol. 2016 Feb;42(1):6-19
pubmed: 26750431
Trends Neurosci. 2017 Jun;40(6):358-370
pubmed: 28527591
Histol Histopathol. 2017 May;32(5):413-431
pubmed: 27775777
Brain Pathol. 2002 Jan;12(1):1-11
pubmed: 11770893
J Histochem Cytochem. 2004 Aug;52(8):991-1000
pubmed: 15258174
J Neurosci. 2020 Nov 4;40(45):8618-8628
pubmed: 33046546
Autophagy. 2021 Jan;17(1):1-382
pubmed: 33634751
Brain. 2017 Apr 1;140(4):878-886
pubmed: 27585855
Histochem Cell Biol. 2008 Aug;130(2):299-313
pubmed: 18553098
Hum Mol Genet. 2019 Jul 15;28(14):2283-2294
pubmed: 31267130
Neurobiol Aging. 2003 Sep;24(5):687-96
pubmed: 12885576
Clin Pharmacokinet. 2004;43(2):83-95
pubmed: 14748618
Hum Mol Genet. 2019 Jan 1;28(1):31-50
pubmed: 30219847
Brain Res. 2007 Jan 19;1129(1):174-90
pubmed: 17157274
J Mol Med (Berl). 2006 Nov;84(11):901-10
pubmed: 16972087
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S62-7
pubmed: 24262191
J Clin Oncol. 2004 May 15;22(10):1926-33
pubmed: 15143086
J Adv Res. 2020 Jan 22;23:37-45
pubmed: 32071790
Int J Mol Sci. 2021 Oct 27;22(21):
pubmed: 34769043
J Neurochem. 2012 Aug;122(4):812-22
pubmed: 22639889
Int J Mol Sci. 2019 Aug 05;20(15):
pubmed: 31387280
J Biol Chem. 2003 Jul 4;278(27):25009-13
pubmed: 12719433
Transl Neurodegener. 2013 Oct 04;2(1):20
pubmed: 24093918
J Histochem Cytochem. 1983 Jan;31(1):101-9
pubmed: 6187796
Int J Mol Sci. 2019 Feb 08;20(3):
pubmed: 30744070
Mol Neurobiol. 2013 Jun;47(3):1081-92
pubmed: 23389286
Cancer. 2000 May 1;88(9):2154-63
pubmed: 10813729
J Neuroimmunol. 2005 Aug;165(1-2):114-20
pubmed: 15949848
J Biol Chem. 2010 Sep 3;285(36):28261-74
pubmed: 20592036
Cancer Chemother Pharmacol. 1994;33(4):325-30
pubmed: 8281627
Micron. 2004;35(4):287-96
pubmed: 15003616